Medicine & Life Sciences
Vaccinia virus
100%
T-Lymphocytes
82%
Poxviridae
48%
Vaccines
36%
HIV-1
33%
Chemokine Receptors
32%
AIDS Vaccines
29%
Neoplasms
29%
Regulatory T-Lymphocytes
27%
Viruses
25%
Antigens
24%
mepazine
23%
Neutrophils
23%
Infections
22%
HIV
21%
Dendritic Cells
19%
nef Gene Products
18%
Immunity
16%
Tumor Microenvironment
16%
Chemokine CXCL10
15%
Pancreatic Neoplasms
14%
CXC Chemokines
14%
Vaccinia
12%
Toll-Like Receptors
12%
Actin Cytoskeleton
11%
Cell- and Tissue-Based Therapy
10%
Genes
10%
Cost-Benefit Analysis
9%
Adaptive Immunity
9%
Intravital Microscopy
8%
C Chemokines
8%
Innate Immunity
8%
Macrophages
8%
Cytokines
8%
Virus Diseases
8%
CD8 Antigens
8%
Transforming Growth Factors
7%
Leishmania LACK antigen
7%
Viral Genes
7%
Cell Movement
7%
Chemokines
7%
Female Genitalia
6%
Inflammation
6%
NYVAC-C vaccine
6%
Proteins
6%
Lymphoid Tissue
6%
Leukocytes
5%
Gene Deletion
5%
DNA
5%
Agriculture & Biology
Vaccinia virus
29%
Human immunodeficiency virus 1
28%
Poxviridae
19%
T-lymphocytes
18%
immune response
16%
viruses
15%
Toll-like receptors
15%
immunogenicity
13%
innate immunity
13%
vector vaccines
12%
microfilaments
12%
mice
11%
vaccines
9%
antigens
9%
chemokine receptors
8%
proteins
8%
infection
7%
adaptive immunity
7%
genes
7%
macrophages
7%
humoral immunity
7%
female genitalia
6%
cytokines
6%
cell movement
6%
immunity
5%
actin
5%
microscopy
5%